AHA today urged the U.S. District Court for the District of Columbia to order the Department of Health and Human Services to promptly repay 340B hospitals for unlawful payment cuts in previous years, given the agency’s continued delay in implementing or even proposing a remedy on its own. 
 
After AHA’s unanimous victory in the U.S. Supreme Court this summer, the D.C. court ordered HHS to halt its unlawful 340B cuts for the remainder of 2022. In a final rule released this week for CY 2023, the agency said it would defer any proposal of a remedy for CYs 2018-2021 until sometime before next year’s CY 2024 payment rule. 
 
“Despite having already sought comment twice, HHS has again deferred announcing any specific remedy proposal and indicated that it will solicit a third round of comments,” AHA told the court today. “But no further public comments are needed for the agency to remediate years of illegal underpayments and for Defendants to promptly pay 340B hospitals the difference between ASP plus 6% and what they were previously paid, without seeking retroactive claw backs in the name of budget neutrality. In fact, following this Court’s September 28 Order with respect to the remainder of 2022, Defendants quickly announced that they would cease their illegal conduct and be able to ‘reprocess claims our contractors paid on or after September 28, 2022.’ By swiftly acceding to the Court’s order, HHS fatally undermined its arguments that such an order would be administratively difficult or unconstitutional.”
 

Related News Articles

Headline
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state’s…
Headline
The AHA June 27 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee that defends the state’s 340B contract pharmacy law…
Chairperson's File
Public
Advocacy is a core part of the work of the AHA, protecting and sustaining what hospitals and health systems need to truly care for our communities. We often…
Headline
A U.S. District Court for the District of Columbia judge June 27 ruled against Johnson & Johnson and sided with the Department of Health and Human Services…
Headline
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater…
Chairperson's File
Public
Advocacy is such an important part of what we do as hospitals and health systems — and what the AHA does on behalf of our field — to help ensure that we get…